Neurogenic and Neurotrophic Effects of BDNF Peptides in Mouse Hippocampal Primary Neuronal Cell Cultures
Open accessThe DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
The level of brain-derived neurotrophic factor (BDNF), a member of the neurotrophin family, is down regulated in Alzheimer's disease (AD), Parkinson's disease (PD), depression, stress, and anxiety; conversely the level of this neurotrophin is increased in autism spectrum disorders. Thus, modulating the level of BDNF can be a potential therapeutic approach for nervous system pathologies. In the present study, we designed five different tetra peptides (peptides B-1 to B-5) corresponding to different active regions of BDNF. These tetra peptides were found to be non-toxic, and they induced the expression of neuronal markers in mouse embryonic day 18 (E18) primary hippocampal neuronal cultures. Additionally, peptide B-5 induced the expression of BDNF and its receptor, TrkB, suggesting a positive feedback mechanism. The BDNF peptides induced only a moderate activation (phosphorylation at Tyr 706) of the TrkB receptor, which could be blocked by the Trk's inhibitor, K252a. Peptide B-3, when combined with BDNF, potentiated the survival effect of this neurotrophin on H(2)O(2)-treated E18 hippocampal cells. Peptides B-3 and B-5 were found to work as partial agonists and as partial antagonists competing with BDNF to activate the TrkB receptor in a dose-dependent manner. Taken together, these results suggest that the described BDNF tetra peptides are neurotrophic, can modulate BDNF signaling in a partial agonist/antagonist way, and offer a novel therapeutic approach to neural pathologies where BDNF levels are dysregulated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“It is often observed that in the presence of the endogenous ligand, a synthetic molecule presents antagonistic properties.”
From Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression (2018) · cites this paper as Cardenas-Aguayo Mdel et al. 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Exercise: a behavioral intervention to enhance brain health and plasticity
Cotman, C. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)02143-4 · Cited by 2,739 · cited 1×
“Physical exercise increases BDNF level in the hippocampus and the cortex, and may enhance learning and memory, synaptic plasticity, and neurogenesis [34].”
BackgroundNeurotrophins and their receptors: A convergence point for many signalling pathways
Chao, M. V. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1078 · Cited by 2,298 · cited 2×
“In contrast to the nonpeptide origin of the small molecules previously used [2] for activating TrkB pathway, these compounds (B-1 to B-5) which also modulate this pathway, are tetrapeptides (derived from the active site of BDNF).”
BackgroundNeurotrophin signal transduction in the nervous system
Kaplan, D. R., & Miller, F. D. (2000) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00092-1 · Cited by 1,944 · cited 2×
“necrosis factor (TNF) receptor super family [1,15], and minimally”
BackgroundSustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action
Tsankova, N. M., Berton, O., Renthal, W., Kumar, A., Neve, R. L., & Nestler, E. J. (2006) · Nature Neuroscience · doi:10.1038/nn1659 · Cited by 1,780 · cited 1×
“Drugs that are able to increase BDNF level in the brain include antidepressants [38] e.”
BackgroundBinder (2004) · doi:10.1080/08977190410001723308 · Cited by 1,481 · cited 4×
“furin generating the mature neurotrophin (molecular weight,14–26 KDa) [13,14].”
BackgroundInfluentialNew insights into BDNF function in depression and anxiety
Martinowich, K., Manji, H., & Lu, B. (2007) · Nature Neuroscience · doi:10.1038/nn1971 · Cited by 1,221 · cited 1×
“Additionally, the expression level of BDNF is also reported to be reduced in Parkinson’s disease (PD), depression, and stress [8,9].”
BackgroundNeuronal Activity–Induced Gadd45b Promotes Epigenetic DNA Demethylation and Adult Neurogenesis
Ma, D. K., Jang, M.-H., Guo, J. U., Kitabatake, Y., Chang, M.-L., Pow-anpongkul, N., Flavell, R. A., Lu, B., Ming, G.-L., & Song, H. (2009) · Science · doi:10.1126/science.1166859 · Cited by 924
BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease
Phillips, H. S., Hains, J. M., Armanini, M., Laramee, G. R., Johnson, S. A., & Winslow, J. W. (1991) · Neuron · doi:10.1016/0896-6273(91)90273-3 · Cited by 921 · cited 1×
“late stages of the disease has been reported [3–7].”
BackgroundPotential therapeutic uses of BDNF in neurological and psychiatric disorders
Nagahara, A. H., & Tuszynski, M. H. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3366 · Cited by 867 · cited 2×
“Alternatively, direct administration of BDNF into the CNS to achieve beneficial neurotrophic effects is a promising approach [27–29], however, there are also some considerations with this strategy that need to be taken into account.”
BackgroundFunctional Interactions of Neurotrophins and Neurotrophin Receptors
Bothwell, M. (1995) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.18.030195.001255 · Cited by 833 · cited 1×
“necrosis factor (TNF) receptor super family [1,15], and minimally”
Background
Cited by
BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases
Lu, B., Nagappan, G., Guan, X., Nathan, P. J., & Wren, P. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3505 · Cited by 743
Gómez-Virgilio, L., Silva-Lucero, M.-D.-C., Flores-Morelos, D.-S., Gallardo-Nieto, J., Lopez-Toledo, G., Abarca-Fernandez, A.-M., Zacapala-Gómez, A.-E., Luna-Muñoz, J., Montiel-Sosa, F., Soto-Rojas, L. O., et al. (2022) · Cells · doi:10.3390/cells11152262 · Cited by 431
Neurobiology of BDNF in fear memory, sensitivity to stress, and stress-related disorders
Notaras, M., & van den Buuse, M. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0639-2 · Cited by 392
Engineering mesenchymal stem cells to improve their exosome efficacy and yield for cell‐free therapy
Phan, J., Kumar, P., Hao, D., Gao, K., Farmer, D., & Wang, A. (2018) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2018.1522236 · Cited by 333
Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression
Levy, M. J. F., Boulle, F., Steinbusch, H. W., van den Hove, D. L. A., Kenis, G., & Lanfumey, L. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4950-4 · Cited by 308
Longo, F. M., & Massa, S. M. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4024 · Cited by 298
Factors that influence adult neurogenesis as potential therapy
Shohayeb, B., Diab, M., Ahmed, M., & Ng, D. C. H. (2018) · Translational Neurodegeneration · doi:10.1186/s40035-018-0109-9 · Cited by 191
“BDNF small peptide mimetic, Peptide B-5, induced the expression of neuronal markers, as well as BDNF and its receptor TrkB, in primary hippocampal neuronal cultures indicating an enhanced neurotrophic effect [55].”
BackgroundBrain-Derived Neurotrophic Factor (BDNF): Novel Insights into Regulation and Genetic Variation
Notaras, M., & van den Buuse, M. (2019) · The Neuroscientist · doi:10.1177/1073858418810142 · Cited by 176
Kazim, S. F., & Iqbal, K. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0119-y · Cited by 115
“Recently, our lab also identified BDNF tetrapeptides (peptide B1-B5) which can modulate TrkB signaling and exert neurotrophic effect in mouse hippocampal primary neuronal cultures [175].”
BackgroundSelf-citationAlzheimer disease therapeutics: Focus on the disease and not just plaques and tangles
Iqbal, K., Liu, F., & Gong, C.-X. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.01.002 · Cited by 109
Self-citationTeixeira, F. G., Panchalingam, K. M., Assunção-Silva, R., Serra, S. C., Mendes-Pinheiro, B., Patrício, P., Jung, S., Anjo, S. I., Manadas, B., Pinto, L., et al. (2016) · Scientific Reports · doi:10.1038/srep27791 · Cited by 112
Kazim, S. F., Blanchard, J., Dai, C.-L., Tung, Y.-C., LaFerla, F. M., Iqbal, I.-G., & Iqbal, K. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.07.001 · Cited by 83
“Primary neuronal cultures were prepared from C57BL/6 mice using the procedure described before (Cardenas-Aguayo et al., 2003, 2013).”
Self-citationYu, L., Liu, S., Zhou, R., Sun, H., Su, X., Liu, Q., Li, S., Ying, J., Zhao, F., Mu, D., et al. (2022) · The FASEB Journal · doi:10.1096/fj.202101654rr · Cited by 87
Yu, D., Zhou, H., Yang, Y., Jiang, Y. L., Wang, T., Lv, L., Zhou, Q., Yang, Y., Dong, X., He, J., et al. (2015) · Hormones and Behavior · doi:10.1016/j.yhbeh.2015.01.003 · Cited by 87
Гудашева, Т. А., Povarnina, P. Y., Тарасюк, А. В., & Середенин, С. Б. (2020) · Medicinal Research Reviews · doi:10.1002/med.21721 · Cited by 62
Unlocking Alzheimer’s Disease: The Role of BDNF Signaling in Neuropathology and Treatment
Alqahtani, S. M., Al-Kuraishy, H. M., Al-Gareeb, A. I., Albuhadily, A. K., Alexiou, A. T., Papadakis, M., Hemeda, L. R., Faheem, S. A., & Batiha, G. E. (2025) · NeuroMolecular Medicine · doi:10.1007/s12017-025-08857-x · Cited by 59
“BDNF tetrapeptides are the partial agonists of TrkB receptors that can reverse neurodegeneration in hippocampal neurons in animal models (Cardenas-Aguayo et al., 2013).”
O’Mahony, A., Godinho, B. M. D. C., Cryan, J. F., & O’Driscoll, C. M. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23672 · Cited by 64
Born to Protect: Leveraging BDNF Against Cognitive Deficit in Alzheimer’s Disease
Caffino, L., Mottarlini, F., & Fumagalli, F. (2020) · CNS Drugs · doi:10.1007/s40263-020-00705-9 · Cited by 56
“To this end, small peptide mimetics exist that can enhance transcription of BDNF through modulation of the Trk receptor, thus rescuing BDNF-deficient situations in experimental models [49].”
BackgroundStem Cell Therapy for Alzheimer’s Disease
Han, F., Bi, J., Qiao, L., & Arancio, O. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-4370-8_4 · Cited by 53
Shimizu, A., Mitani, T., Tanaka, S., Fujii, H., Maebuchi, M., Amiya, Y., Tanaka, M., Matsui, T., Nakamura, S., & Katayama, S. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b01581 · Cited by 52
Szarowicz, C. A., Steece‐Collier, K., & Caulfield, M. E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23148011 · Cited by 47
Li, E.-Y., Zhao, P., Jian, J., Yin, B.-Q., Sun, Z., Xu, C., Tang, Y., & Wu, H. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1638190 · Cited by 42
“Brain-derived neurotrophic factor (BDNF) is a kind of neurotrophins that has critical roles in the development of central nervous system (CNS) and neurons survival, differentiation, and growth [8,9]; and up-regulation of BDNF significantly restrained apoptosis of hippocampal neurons [10].”
BackgroundHuang, X., Li, M., Bruni, R., Messa, P., & Cellesi, F. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.03.090 · Cited by 36
Badihian, N., Daniali, S. S., & Kelishadi, R. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.12.018 · Cited by 40
Wang, Y., Feng, Y., FU, Q., & Li, L. (2013) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2013.1215 · Cited by 33
“Increased BDNF expression in the brain may improve neuronal survival (33,34), resulting in a delay in or prevention of AD progression.”
MOSTAFA, M., Disouky, A., & Lazarov, O. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2025.e00580 · Cited by 34
Growth factors and their peptide mimetics for treatment of traumatic brain injury
Atkinson, E. A., & Dickman, R. (2023) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2023.117368 · Cited by 31
“207 This evidence that low molecular weight peptides can protect neurons against oxidative stress and toxicity suggests that these compounds may have potential as neuroprotective agents for ameliorating secondary injury in TBI.”
Emerging roles of bioactive peptides on brain health promotion
Katayama, S., & Nakamura, S. (2018) · International Journal of Food Science & Technology · doi:10.1111/ijfs.14076 · Cited by 34
Potential of plant-derived peptides for the improvement of memory and cognitive function
Katayama, S., Corpuz, H. M., & Nakamura, S. (2021) · Peptides · doi:10.1016/j.peptides.2021.170571 · Cited by 31
Гудашева, Т. А., Povarnina, P. Y., Тарасюк, А. В., & Середенин, С. Б. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190329122852 · Cited by 30
Zagrebelsky, M., & Körte, M. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.374138 · Cited by 30
Oroxylin A enhances memory consolidation through the brain-derived neurotrophic factor in mice
Kim, D. H., Lee, Y., Lee, H. E., Park, S. J., Jeon, S. J., Jeon, S. J., Cheong, J. H., Shin, C. Y., Son, K. H., & Ryu, J. H. (2014) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2014.09.001 · Cited by 28
Yoo, H. J., Yang, S. Y., Cho, I. H., Park, M., & Kim, S. A. (2014) · Psychiatry Investigation · doi:10.4306/pi.2014.11.3.319 · Cited by 28
Zhang, Q., Su, G., Zhao, T., Sun, B., Zheng, L. P., & Zhao, M. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.103690 · Cited by 26
Yu, S. B., Baek, J., Choi, M., Oh, Y., Lee, H. R., Yu, S. J., Lee, E., Sohn, J., Im, S. G., & Jon, S. (2016) · ACS Nano · doi:10.1021/acsnano.6b03527 · Cited by 24
Peptides Derived from Growth Factors to Treat Alzheimer’s Disease
Gascon, S., Jann, J., Langlois-Blais, C., Plourde, M., Lavoie, C. L., & Faucheux, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116071 · Cited by 25
“Both B-5 and B-3 were found to work as partial agonists and antagonists for TrkB activation, and also to induce the expression of TrkB and BDNF (Table 2) [237].”
BackgroundKazim, S. F., Cárdenas‐Aguayo, M. D. C., Arif, M., Blanchard, J., Fayyaz, F., Grundke, I., & Iqbal, K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118627 · Cited by 25
Self-citationIncontinence products and devices for the elderly.
Newman, D. K. (2004) · PubMed · Cited by 30
Xu, J., & Chau, Y. (2018) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2018.08.020 · Cited by 22
Baazaoui, N., & Iqbal, K. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170075 · Cited by 21
“Brain-derived neurotrophic factor (BDNF) agonists, for example, were shown to have neuroprotective effects and reverse synaptic and neuronal loss as well as cognitive impairment in several in vitro and in vivo animal models [16–26].”
Self-citationLucaci, A. G., Notaras, M. J., Pond, S. L. K., & Colak, D. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02021-w · Cited by 21
“, glycosylation [35]), as well as catalytic processing, trafficking, and composition [36].”
BackgroundEffects of Padel Competition on Brain Health-Related Myokines
Pradas, F., Cádiz, M. P., Nestares, M. T., Martínez-Díaz, I. C., & Carrasco, L. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18116042 · Cited by 18
Faye, P.-A., Védrenne, N., Miressi, F., Rassat, M., Romanenko, S., Richard, L., Bourthoumieu, S., Funalot, B., Sturtz, F. G., Favreau, F. D., et al. (2020) · Brain Sciences · doi:10.3390/brainsci10070407 · Cited by 19
Székiová, E., Slovinská, L., Blaško, J., Plšíková, J., & Cizkova, D. (2018) · Neurological Research · doi:10.1080/01616412.2018.1432266 · Cited by 17
Guibinga, G.-H., Barron, N., & Pandori, W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096575 · Cited by 17
“Thus in the context of LNS, BDNF may be amenable to therapeutic modulation as suggested for other neurological disorders [60].”
BackgroundŁuczkowski, M. (2016) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2016.03.001 · Cited by 18
Self-assembly of trifunctional tripeptides to form neural scaffolds
Kulkarni, K., Kelderman, J. T. A., Coleman, H. A., Aguilar, M., Parkington, H. C., & Borgo, M. P. D. (2021) · Journal of Materials Chemistry B · doi:10.1039/d0tb02959a · Cited by 16
Xu, F., Wang, X., Cai, X., Liu, J., Guo, J.-W., Yang, F., Chen, W., Schonewille, M., Zeeuw, C. I. D., Zhou, L., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113559 · Cited by 16
“Our data align well with the study by Krishnan et al. 39 demonstrating that disruption of MeCP2 function increases PTP1B levelsand thereby decreases the tyrosine phosphorylation of TrkB.”
MethodInfluentialde Faria, R. S., Sartori, C. R., Canova, F. B., & Ferrari, E. A. M. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.09.054 · Cited by 17
Kazmerova, Z., Žilka, N., Cente, M., Neradil, P., Žilková, M., & Novák, M. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130572 · Cited by 15
“Several investigators showed that administration of different neurotrophic molecules such as BDNF, NGF, ciliary neurotrophic factor (CNTF), and fibroblast growth factor (FGF) as well as their peptides, can modulate neuronal survival and synaptic connectivity in AD – induced neurodegeneration [116, 118–121].”
BackgroundNeurotrophin Strategies for Neuroprotection: Are They Sufficient?
Steiner, J. P., & Nath, A. (2014) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-014-9533-5 · Cited by 13
Research progress in animal models and stem cell therapy for Alzheimer’s disease
Han, F., Wang, W., & Chen, C. (2014) · Journal of Neurorestoratology · doi:10.2147/jn.s74160 · Cited by 19
“Certain tetrapeptides corresponding to the active regions of brain-derived neurotrophic factor (BDNF) were also found to induce expression of neuronal markers in primary hippocampal neuronal cultures of mouse embryonic day 18, suggesting that BDNF tetrapeptides could modulate BDNF signaling to improve neurogenesis.(49…”
Alzheimer's disease research in Ibero America
Snyder, H. M., Cárdenas‐Aguayo, M. D. C., Alonso, A. D. C., Bain, L. J., Iqbal, K., & Carrillo, M. C. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.04.007 · Cited by 12
“Three of the tetra peptides were shown to have both neurotrophic and neuroprotective activities in neuronal cell cultures [33].”
BackgroundSelf-citationSazonova, N. M., Тарасюк, А. В., Шумский, А. Н., Povarnina, P. Y., Круглов, С. В., Антипова, Т. А., Гудашева, Т. А., & Середенин, С. Б. (2018) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-018-1896-0 · Cited by 9
Zhang, Q., Zheng, L. P., Su, G., Luo, D., Huang, M., Feng, Y., & Zhao, M. (2022) · Food Bioscience · doi:10.1016/j.fbio.2022.101696 · Cited by 9
Ding, X., Chen, Y., Zhang, X., Duan, Y., Yuan, G., & Liu, C. (2024) · Neuropeptides · doi:10.1016/j.npep.2024.102457 · Cited by 8
Neurotrophin peptidomimetics for the treatment of neurodegenerative diseases
Madhubala, D., Mahato, R., Khan, M. R., Bala, A., & Mukherjee, A. K. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.104156 · Cited by 8
Tracing vitamins on the long non-coding lane of the transcriptome: vitamin regulation of LncRNAs
Yazarlou, F., Alizadeh, F., Lipovich, L., Giordo, R., & Ghafouri‐Fard, S. (2024) · Genes & Nutrition · doi:10.1186/s12263-024-00739-4 · Cited by 7
“Vitamins B1 and B12 suppressed neuronal apoptosis by upregulating BDNF (brain-derived neurotrophic factor) [93], a promoter of neuronal survival [101].”
BackgroundPeptide‐Incorporated Biomaterials Promote Regeneration of Peripheral Nerve Injuries
Zhao, Z., Liu, J., Li, J., Li, D., Ding, J., & Liu, B. (2026) · Advanced Science · doi:10.1002/advs.202524264 · Cited by 6
“It was identified by Cardenas-Aguayo et al. through screening a series of short peptides, mainly tetrapeptides, designed to mimic the function of BDNF while enhancing its permeability and stability [ 50 ].”
Kumar, A., Goyal, K., Pal, M., Upadhyay, P., Gupta, S., Koul, V., & Konar, A. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.25.497622 · Cited by 4
“Cells were seeded in complete neurobasal medium supplemented with 2% B27 and 2mM glutamax and incubated in a humidified 5% CO2/95% air atmosphere at 37 °C (Cardenas-Aguayo Mdel et al., 2013).”
MethodHuang, X., Li, M., Espinoza, M. I. M., Zennaro, C., Bossi, F., Lonati, C., Oldoni, S., Castellano, G., Alfieri, C., Messa, P., et al. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124322 · Cited by 3
Mitochondrial fusion targeted supramolecular peptide hydrogel for gut neuroprotection
Sun, W., Han, L., Bi, Y., Yin, F., Li, R., Tong, Y., Zhang, J., Ding, D., & Sun, D. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2026.124061 · Cited by 3
Nanoparticles for drug delivery targeting neurodegeneration in brain and eye
Teng, F., Huang, X., Ni, R., Suen, W. L. L., & Chau, Y. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816505-8.00006-0 · Cited by 3
Neural Regeneration as a Disease-Modifying Therapeutic Strategy for Alzheimer’s Disease
Kazim, S. F., & Iqbal, K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803690-7.00002-8 · Cited by 3
Self-citationLevy, M. J. F. (2017) · theses.fr (ABES) · doi:10.70675/be792343za725z4b2czb8c5z8a26a8113d23 · Cited by 3
Bioactive Peptides Produced From Microbial Sources and Their Neuroprotective Effects
Konuk, M., & Korcan, S. E. (2026) · IGI Global eBooks · doi:10.4018/979-8-3373-4139-2.ch003 · Cited by 1
Ali, L. H., Khalaf, H. A., Hamed, S. H., Helaly, A. M., Maghrabia, A. E., Ghorab, D. S., & Bakary, A. A. E. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48070714 · Cited by 1
“Meta-analysis studies demonstrated a high serum level of BDNF in autism, unlike schizophrenia, and it has been suggested that BDNF is not merely a response marker but may also be involved in the pathogenesis of the disorder [28,29].”
Brain-Derived Neurotrophic Factor is Produced in Escherichia Coli Using Transforming Plasmids
Taherian, R., & Taherian, M. (2016) · International Clinical Neuroscience Journal · doi:10.22037/icnj.v3i1.12353 · Cited by 1
Karimi, Z., Zarifkar, A., Mirzaei, E., Dianatpour, M., Dara, M., & Aligholi, H. (2024) · International Journal of Developmental Neuroscience · doi:10.1002/jdn.10348 · Cited by 1
“Several studies have reported increased levels of BDNF in plasma, serum, and in the brain of autistic individuals (Cardenas-Aguayo et al., 2013; Miyazaki et al., 2004; Nelson et al., 2001).”
Ge, X., Wekselblatt, J. B., Elmore, S. T., Wang, B., Wang, T., Dai, R., Zhang, T., Dave, H., Ghaderi, M., Anilkumar, A. R., et al. (2025) · Advanced Science · doi:10.1002/advs.202501033 · Cited by 1
Primary Hippocampal Cell Culture and Its Application in Medical Researches
Atik, N., Nandika, A., Avriyanti, E., Bhatara, T., & Kartiwa, R. A. (2019) · Global Medical & Health Communication (GMHC) · doi:10.29313/gmhc.v7i1.4245
“Also, B-3 peptide that is one of the five tetrapeptides tested has a potential neuroprotective effect on the toxicity of H2O2.”
BackgroundEffects of Dexamethasone and Brain-Derived Neurotropic Factor in NT2 Cells
Alharthi, S., Tchao, R., & Tejani‐Butt, S. M. (2020) · International Journal of Sciences: Basic and Applied Research
Isolation and functional characterization of novel neuropeptides regulating hippocampal neurogenesis
Marefat, A., Sadeghi, L., & Dehghan, G. (2026) · Neuropeptides · doi:10.1016/j.npep.2026.102650
Metadata
- Authors
- Cardenas-Aguayo, M. D. C., Kazim, S. F., Grundke-Iqbal, I., & Iqbal, K.
- Affiliations
- State University of New York (US)
- Corresponding author
- Iqbal, Khalid
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-01-08
- Volume
- 8
- Issue
- 1
- Pages
- e53596
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3539976
- OpenAlex
- W2038374013
- Cited by
- 73
- References
- 62
- Citations by year
- 2026: 5 · 2025: 3 · 2024: 5 · 2023: 3 · 2022: 6 · 2021: 4 · 2020: 6 · 2019: 6 · 2018: 9 · 2017: 3 · 2016: 7 · 2015: 2 · 2014: 7 · 2013: 6
- FWCI
- 3.60
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacological Receptor Mechanisms and Effects
- Keywords
- brain-derived neurotrophic factor, TrkB receptor, hippocampal neurons, neurotrophic peptides, TrkB phosphorylation, K252a, neuroprotection, neurodegenerative diseases
- MeSH terms
- Amino Acid Sequence, Animals, Cells, Cultured, Hippocampus, Molecular Sequence Data, Nerve Growth Factors, Neurons, Oligopeptides, Peptide Fragments, Biomarkers, Neuroprotective Agents, Brain-Derived Neurotrophic Factor, Receptor, trkB, Mice, Neurogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.